Newsroom
Sorted by: Latest
-
Drug Farm Completes First Closing of $55 Million Series D Financing to Advance Clinical and Preclinical Development Pipeline
SHANGHAI & ALBANY, N.Y.--(BUSINESS WIRE)--Drug Farm today announced the successful first closing of its $55 million Series D financing. The financing round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund Partnership Enterprise, with participation from new investors Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investment Fund, and Keyuan Pharma. Existing investors, including BioVeda China Fund (BVCF), YD C...
-
Vertical Aerospace Shares Business Update Ahead of Farnborough International Airshow
LONDON--(BUSINESS WIRE)--Vertical Aerospace ("Vertical" or the "Company") (NYSE: EVTL), a global aerospace and technology company that is pioneering electric aviation, today provided a business update ahead of Farnborough International Airshow, highlighting progress across its programme, as it prepares for the next phase of development and entry into service. Program Progress & Critical Design Review In April 2026, Vertical achieved the most significant technical milestone in its history, w...
-
NOG Provides Second Quarter Operational Update
MINNEAPOLIS--(BUSINESS WIRE)--Northern Oil and Gas, Inc. (NYSE: NOG) (“NOG” or the “Company”) today provided an update on several business matters including second quarter hedging results, an update on ground game transactions and shareholder returns. HIGHLIGHTS NOG reiterates 2026 production and capital expenditure guidance Strong second quarter for the Ground Game closing on over 2,300 net acres and 6.2 net wells On June 1, closed the previously announced Duvernay Joint Development acquisitio...
-
Zip Opens New York City Hub, Plans to Double Local Team
SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Zip opens NYC hub in former Twitter building; flagship Zip Forward conference debuts in NYC this fall with speakers from Visa, Shopify, and Uber...
-
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross proceeds, before the deduction of private placement expenses, and up to an additional $255 million upon the full exercise of purchase warrants. The financing was led by Commodore Capital, with participation from RA Capital Management, TCGX, Invus, and L...
-
PLAB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Photronics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The case alleges Photronics and its top executives made false and/or misleading statements to investors....
-
Mill Point Capital Completes the Acquisition of Total Safety Supplies & Solutions
FAIRFIELD, Calif.--(BUSINESS WIRE)--Mill Point Capital LLC ("Mill Point") is pleased to announce the acquisition of Total Safety Supplies & Solutions, Inc. ("S&S" or the "Company"), a leading distributor of industrial maintenance, repair, and operations (“MRO”) products including safety, and personal protective equipment ("PPE"). The acquisition of S&S, a division of Total Safety U.S., Inc. (“Total Safety”), represents Mill Point’s 20th corporate carve-out and underscores Mill Point...
-
Emera Declares Quarterly Dividends
HALIFAX, Nova Scotia--(BUSINESS WIRE)--On July 13, 2026, the Board of Directors of Emera Inc. (TSX/NYSE: EMA) declared quarterly dividends on its common shares and First Preferred Shares, each of which is payable on and after August 17, 2026 to the applicable shareholders of record at the close of business on August 3, 2026, as follows: $0.7325 per common share; $0.3094 per Series A First Preferred Share; $0.40213 per Series C First Preferred Share; $0.28125 per Series E First Preferred Share;...
-
Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation...
-
Genethon’s Recent Accomplishments Underscore the Progress of Genetic Medicine from Scientific Promise to Clinical Reality
PARIS--(BUSINESS WIRE)--Genethon highlights latest advances in AAV vectors,
Duchenne muscular dystrophy, limb-girdle muscular dystrophy and Crigler-Najjar syndrome....